Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

OBJECTIVES: To assess the tolerance and efficacy of targeted therapies prescribed off-label in refractory low-prevalence autoimmune and inflammatory systemic diseases. METHODS: The TATA registry (TArgeted Therapy in Autoimmune Diseases) is a prospective, observational, national and independent cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottenberg, Jacques-Eric, Chaudier, Aurore, Allenbach, Yves, Mekinian, Arsène, Amoura, Zahir, Cacoub, Patrice, Cornec, Divi, Hachulla, Eric, Quartier, Pierre, Melki, Isabelle, Richez, Christophe, Seror, Raphaele, Terrier, Benjamin, Devauchelle-Pensec, Valérie, Henry, Julien, Gatfosse, Marc, Bouillet, Laurence, Gaigneux, Emeline, Andre, Vincent, Baulier, Gildas, Saunier, Aurélie, Desmurs, Marie, Poulet, Antoine, Ete, Mathieu, Bienvenu, Boris, Truchetet, Marie-Elise, Michaud, Martin, Larroche, Claire, Dellal, Azeddine, Leurs, Amélie, Ottaviani, Sebastien, Nielly, Hubert, Vial, Guillaume, Jaussaud, Roland, Rouvière, Bénedicte, Jeandel, Pierre-Yves, Guffroy, Aurelien, Korganow, Anne-Sophie, Jouvray, Mathieu, Meyer, Alain, Chatelus, Emmanuel, Sordet, Christelle, Felten, Renaud, Sibilia, Jean, Litim-Ahmed-Yahia, Samira, Kleinmann, Jean-Francois, Mariette, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628685/
https://www.ncbi.nlm.nih.gov/pubmed/36319066
http://dx.doi.org/10.1136/rmdopen-2022-002324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628685/
https://www.ncbi.nlm.nih.gov/pubmed/36319066
http://dx.doi.org/10.1136/rmdopen-2022-002324

Ejemplares similares